Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Issue 3 (March 2015)
- Record Type:
- Journal Article
- Title:
- Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Issue 3 (March 2015)
- Main Title:
- Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
- Authors:
- Armenian, Saro H
Hudson, Melissa M
Mulder, Renee L
Chen, Ming Hui
Constine, Louis S
Dwyer, Mary
Nathan, Paul C
Tissing, Wim J E
Shankar, Sadhna
Sieswerda, Elske
Skinner, Rod
Steinberger, Julia
van Dalen, Elvira C
van der Pal, Helena
Wallace, W Hamish
Levitt, Gill
Kremer, Leontien C M - Abstract:
- Summary: Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation are at an increased risk of developing congestive heart failure. In this population, congestive heart failure is well recognised as a progressive disorder, with a variable period of asymptomatic cardiomyopathy that precedes signs and symptoms. As a result, several clinical practice guidelines have been developed independently to help with detection and treatment of asymptomatic cardiomyopathy. These guidelines differ with regards to definitions of at-risk populations, surveillance modality and frequency, and recommendations for interventions. Differences between these guidelines could hinder the effective implementation of these recommendations. We report on the results of an international collaboration to harmonise existing cardiomyopathy surveillance recommendations using an evidence-based approach that relied on standardised definitions for outcomes of interest and transparent presentation of the quality of the evidence. The resultant recommendations were graded according to the quality of the evidence and the potential benefit gained from early detection and intervention.
- Is Part Of:
- Lancet oncology. Volume 16:Issue 3(2015:Mar.)
- Journal:
- Lancet oncology
- Issue:
- Volume 16:Issue 3(2015:Mar.)
- Issue Display:
- Volume 16, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 16
- Issue:
- 3
- Issue Sort Value:
- 2015-0016-0003-0000
- Page Start:
- e123
- Page End:
- e136
- Publication Date:
- 2015-03
- Subjects:
- Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S1470-2045(14)70409-7 ↗
- Languages:
- English
- ISSNs:
- 1470-2045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4901.xml